Systemic vasculitis in myelodysplastic syndromes

Netherlands Journal of Medicine

Volumn 70, Issue 2, 2012, Pages 63-68

  Oostvogels, R ^a   Petersen, E J ^a   Chauffaille, M L ^b   Abrahams, A C ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Chronic myelomonocytic leukaemia; Myelodysplastic syndromes; Polyarteritis nodosa; Vasculitis

Indexed keywords

CORTICOSTEROID; CYTARABINE; IDARUBICIN;

ADULT; AUTOIMMUNE DISEASE; BLEEDING; CASE REPORT; CHRONIC MYELOMONOCYTIC LEUKEMIA; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DRUG MEGADOSE; FEVER; HEMOPTYSIS; HUMAN; HYPOVOLEMIC SHOCK; INDUCTION CHEMOTHERAPY; INFARCTION; MALE; MICROANEURYSM; MYELODYSPLASTIC SYNDROME; PATHOPHYSIOLOGY; POLYARTERITIS NODOSA; RESPIRATORY FAILURE; REVIEW; SPLENECTOMY; SPLENOMEGALY; SYSTEMIC VASCULITIS; UPPER ABDOMINAL PAIN;

ADRENAL CORTEX HORMONES; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMORBIDITY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; MALE; MYELODYSPLASTIC SYNDROMES; PROGNOSIS; SYSTEMIC VASCULITIS;

EID: 84858613004     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002; 100(7): 2292-302.
2. Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009; 114(5): 937-951.
3. Tefferi A, Elliott MA, Pardanani A. Atypical myeloproliferative disorders: diagnosis and management. Mayo Clin Proc. 2006;81(4):553-563.
4. Orazi A, Germing U. The myelodysplastic/ myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features. Leukemia. 2008;22:1308-1319.
5. Rollison DE, Howlader N, Smith MT, et al. Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs. Blood. 2008;112(1):45-52.
6. Pirayesh A, Verbunt RJAM, Kluin PM, et al. Myelodysplastic syndrome with vasculitic manifestations. J Int Med. 1997;242:425-431.
7. Saif MW, Hopkins JL, Gore SD. Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia. Leuk Lymphoma. 2002;43(11):2083-2092.
8. Enright H, Jacob HS, Vercelotti G, et al. Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy. Br J Haematology. 1995;91(2):403-408.
9. Lightfoot RW, Michel BA Jr, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum. 1990;33:1088-1093.
10. Kallenberg CG. The last classification of vasculitis. Clin Rev Allergy Immunol. 2008;35: 5-10.
11. Hamidou MA, Derenne S, Audrain MAP, et al. Prevalence of rheumatic manifestations and antineutrophil cytoplasmic antibodies in haematological malignancies. A prospective study. Rheumatology. 2000;39:417-420.
12. Lopez FF, Vaidyan PB, Mega AE, Schiffman FJ. Aortitis as a manifestation of myelodysplastic syndrome. Postgrad Med J. 2001;77(904):116-118.
13. Espinosa G, Font J, Muñoz-Rodríguez FJ, et al. Myelodysplastic and myeloproliferative syndromes associated with giant cell arteritis and polymyalgia rheumatica: a coincidental coexistence or a causal relationship? Clin Rheumatol. 2002;21(4):309-313.
14. Hamidou MA, Boumalassa A, Larroche C, et al. Systemic medium-sized vessel vasculitis associated with chronic myelomonocytic leukemia. Semin Arthritis Rheum. 2001;31:119-126.
15. Mahr A, Guillevin L, Poissonnet M, et al. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis Rheum. 2004;51(1):92-99.
16. Mohammad AJ, Jacobsson LT, Mahr AD, Sturfeld G, Segelmark M. Prevalence of Wegener's granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden. Rheumatology 2007;46(8):1329-1337
17. Fain O, Hamidou M, Cacoub P, Godeau B, Wechsler B, Pariès J, et al. Vasculitides associated with malignancies: analysis of sixty patients. Arthritis Rheum. 2007 Dec 15;57(8):1473-1480.
18. Rosen AM, Haines K 3rd, Tallman MS, Hakimian D, Ramsey-Goldman R. Rapidly progressive cutaneous vasculitis in a patient with chronic myelomonocytic leukemia. Am J Hematol. 1995 Dec; 50(4):310-312.
19. Aslangul-Castier E, Papo T, Amoura Z, Baud O, Leblond V, Charlotte F, et al. Systemic vasculitis with bilateral perirenal haemorrhage in chronic myelomonocytic leukaemia. Ann Rheum Dis. 2000 May;59(5):390-393.
20. Brickner LA, Scannell KA. Medium-vessel PAN-type vasculitis associated with myelodysplastic syndrome and presenting as bilateral perinephric hematomas. Clin Exp Rheumatol. 1997;15(2):221-222.
21. Presti JC, Carroll PR. Bilateral spontaneous renal haemorrhage due to polyarteritis nodosa. West J Med. 1991;155:527-528.
22. Hollanda A, Beucher A, Henrion D, et al. Systemic and immune manifestations in myelodysplasia. A multicenter retrospective study. Arthritis Care Res. 2011;63(8):1188-1194.
23. Giannouli S, Voulgarelis M, Zintzaras E, et al. Autoimmune phenomena in myelodysplastic syndromes: a 4-yr prospective study. Rheumatology. 2004;43:626-632.
24. Shetty V, Allampallam K, Raza A. Increased macrophages, high serum M-CSF and low serum cholesterol in myelodysplasia and Kawasaki disease. Br J Haematol. 1999;106:1068-1070.
25. Voulgarelis M, Giannouli S, Ritis K, Tzioufas AG. Myelodysplasiaassociated autoimmunity: clinical and pathophysiologic concepts. Eur J Clin Inv. 2004;34:690-700.
26. Thielen N, Ossenkoppele G, Schuurhuis GJ, Janssen J. New insights in the pathogenesis of chronic myeloid leukemia: towards a path to cure. Neth J Med. 2011;10:430-440.
27. Pinheiro RF, Metze K, Silva MRR, Chauffaille ML. The ambiguous role of interferon regulatory factor-1 (IRF-1) immunoexpression inmyelodysplastic syndrome. Leuk Res. 2009;33:1308-1312.
28. Liebermann DA, Hoffman B. Good and bad IRF-1: Role in tumor suppression versus autoimmune disease. Leuk Res. 2009; 33:1301-1302.
29. Giannouli S, Tzoanopoulos D, Ritis K, et al. Autoimmune manifestations in human myelodysplasia: a positive correlation with interferon regulatory factor-1 (IRF-1) expression. Ann Rheum Dis. 2004;63(5):578-582.
30. Incalzi RA, Arena V, Capelli A, Gambassi G. Isolated PACNS-like presentation of a systemic vasculitis complicating a myelodysplastic syndrome. J Intern Med. 2004;255(6):674-679.
31. Belizna CC, Kerleau JM, Heron F, et al. Vasculitis and myelodysplasia. Isr Med Assoc J. 2008;10(2):156-157.
32. Steurer M, Fritsche G, Tzankov A, et al. Large-vessel arteritis and myelodysplastic syndrome: report of two cases. Eur J Haematol. 2004;73(2):128-133.
33. Warren AJ, Hegde UM, Nathwani A, Reilly IAG. Systemic vasculitis and myelodysplasia. Br J Haematol. 1990;75:627-629.
34. Leung AC, McLay A, Boulton-Jones JM. Polyarteritis nodosa and monocytic leukaemia. Postgrad Med J 1986;62(723):35-37.
35. van Rijn RS, Wittebol S, Graafland AD, Kramer MH. Immunologic phenomena as the first sign of myelodysplastic syndrome. Ned Tijdschr Geneeskd. 2001;145(32):1529-1233.
36. Philippe B, Couderc LJ, Droz D, et al. Systemic vasculitis and myelodysplastic syndromes. A report of two cases. Arthritis Rheum. 1997;40(1):179-182.
37. Smail A, Ducroix JP, Sahir R, et al. Wegener's disease and myelomonocytic leukemia: a fortuitous association? Rev Med Interne. 1989;10(5):463-465.
38. Taillan B, Ferrari E, Garnier G, et al. Association of Wegener's disease and myelodysplastic syndrome. Ann Med Interne (Paris). 1992;143(7):478-479.
39. Constans J, Vidal E, Conri C, et al. Periarteritis nodosa and preleukemic states. Ann Med Interne (Paris). 1992;143(7):477-8.
40. Fernández-Miranda C, García-Marcilla A, Martín M, et al. Vasculitis associated with a myelodysplastic syndrome: a report of 5 cases. Med Clin (Barc). 1994 Oct 29;103(14):539-42.
41. Roy-Peaud F, Paccalin M, Le Moal G, et al. Association of systemic diseases and myelodysplastic syndromes. A retrospective study of 14 cases. Presse Med. 2003 Mar 29;32(12):538-43.
42. Berthier S, Magy N, Gil H, et al. Myelodysplasias and systemic diseases. A non-fortuitous association. Rev Med Interne. 2001 May;22(5):428-432.
43. Park JK, Gelber AC, Zheng G, et al. Large vessel vasculitis as an early manifestation of chronic myelomonocytic leukemia. J Clin Oncol. 2011; 29(20):e601-e603.
44. Cohen MJ, Shyman A, Klein M, et al. Large vessel (Takayasu's) arteritis in a patient with myelodysplastic syndrome: is there a common pathogenesis? Clin Lymphoma Myeloma Leuk. 2011;11(1):60-63.